These final results, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a unique method to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated Diseases. Title your selection: Name have https://soichiroh283zrj0.develop-blog.com/profile